Li Dean Y Insider Trades

Insider Trading History

Track insider trading activity for Li Dean Y. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
MerckInc
MerckInc MRK
Executive VP & President, MRL
Holding Value $6.96M 58,207 shares
Last Trade
May 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.84M 78,092 shares
$113.16
$119.60
MerckInc
MerckInc MRK
Executive VP & President, MRL
Holding Value $11.3M 94,431 shares
Last Trade
Apr 29, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$256k 2,326 shares
$110.03
$119.60
MerckInc
MerckInc MRK
Executive VP & President, MRL
Holding Value $11.6M 96,757 shares
Last Trade
Apr 29, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$520k 4,722 shares
$110.03
$119.60
MerckInc
MerckInc MRK
Executive VP & President, MRL
Holding Value $1.13M 9,444 shares
Last Trade
Apr 29, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$524k 4,722 shares
$111.02
$119.60
Recursion Pharmaceuticals
Recursion Pharmaceuticals RXRX
Director
Holding Value $3.94M 1,244,177 shares
Last Trade
Apr 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10k 3,268 shares
$3.06
$3.17
MerckInc
MerckInc MRK
Executive VP & President, MRL
Holding Value $11M 92,035 shares
Last Trade
Feb 10, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.2M 10,235 shares
$117.52
$119.60
MerckInc
MerckInc MRK
Executive VP & President, MRL
Holding Value $0 0 shares
Last Trade
Feb 04, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.8M 15,087 shares
$119.64
$119.60
MerckInc
MerckInc MRK
Executive VP & President, MRL
Holding Value $14M 117,357 shares
Last Trade
Feb 04, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.8M 15,087 shares
$119.64
$119.60
MerckInc
MerckInc MRK
Executive VP & President, MRL
Holding Value $12.2M 102,270 shares
Last Trade
Feb 04, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.79M 15,087 shares
$118.77
$119.60
MerckInc
MerckInc MRK
Executive VP & President, MRL
Holding Value $12.2M 102,270 shares
Last Trade
Jan 26, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.2M 20,469 shares
$107.40
$119.60
Recursion Pharmaceuticals
Recursion Pharmaceuticals RXRX
Director
Holding Value $3.93M 1,240,909 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10k 2,381 shares
$4.20
$3.17
Recursion Pharmaceuticals
Recursion Pharmaceuticals RXRX
Director
Holding Value $3.93M 1,238,528 shares
Last Trade
Oct 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10k 1,961 shares
$5.10
$3.17
Recursion Pharmaceuticals
Recursion Pharmaceuticals RXRX
Director
Holding Value $3.92M 1,236,567 shares
Last Trade
Jul 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10k 1,949 shares
$5.13
$3.17
Recursion Pharmaceuticals
Recursion Pharmaceuticals RXRX
Director
Holding Value $3.91M 1,234,618 shares
Last Trade
Jun 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$225k 44,031 shares
$5.11
$3.17
MerckInc
MerckInc MRK
Executive VP & President, MRL
Holding Value $7.71M 64,481 shares
Last Trade
Apr 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.46M 64,481 shares
$84.71
$119.60
Recursion Pharmaceuticals
Recursion Pharmaceuticals RXRX
Director
Holding Value $252k 79,618 shares
Last Trade
Apr 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.6k 2,268 shares
$5.10
$3.17
MerckInc
MerckInc MRK
Executive VP & President, MRL
Holding Value $9.52M 79,592 shares
Last Trade
Jan 27, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.19M 32,621 shares
$97.94
$119.60
Recursion Pharmaceuticals
Recursion Pharmaceuticals RXRX
Director
Holding Value $245k 77,350 shares
Last Trade
Jan 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.9k 1,647 shares
$7.21
$3.17
Recursion Pharmaceuticals
Recursion Pharmaceuticals RXRX
Director
Holding Value $240k 75,703 shares
Last Trade
Oct 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.9k 1,925 shares
$6.17
$3.17
Recursion Pharmaceuticals
Recursion Pharmaceuticals RXRX
Director
Holding Value $234k 73,778 shares
Last Trade
Jul 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.9k 1,592 shares
$7.46
$3.17

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up